More Videos- Tommy Lee, Medical Tourism and Nasty Santa, Your Emails
- Tommy Lee Wants You to Be a Rock Star
- The Gift That Stops Giving
- Smile Though Your Head Is Breaking...
- How Low Will You Go?
- The Perfect Job On 'The Go'
- Balloon Boy Flies Again — As Halloween Hit
- Barbie's Sugar Daddy?
- What Ribbon To Wear For National Toilet Month?
- Does Uncle Sam Want You To Get The H1N1 Vaccine?
MOST SHARED
- Obama Sees Strains Unless US, China Balance Growth
- Future of Marketing
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- European Commission Objects to Sun Micro-Oracle Deal
- Mad Mail: Buy the Berkshire Hathaway Split?
- Priceline Crushes Profit Forecasts; Shares Jump
- Oil Tomorrow
- Sprint to Cut Up to 2,500 Jobs, Sees Charge
- Cramer: 5 Stocks to Play the Next Bull Run
- GM CEO Starts Opel Charm Tour in Germany
- Why Google is Paying $750 Million for Ad Mob
- Warren Buffett to Sell Stakes In Union Pacific & Norfolk Southern
- Nov. 9: Unusual Volume Leaders
- The Battered Businesses Behind Housing
- Modern Warfare 2's Record-Breaking Launch
- Merck’s Mega-Monday Morning
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- S&P Stocks Trading at New 52-Week Highs
- Fed's Tarullo Backs Surcharges to Limit Bank Size
- Look Ahead: 'Risk On' Sentiment Could Fuel Rally Further
- European Commission Objects to Sun Micro-Oracle Deal
- Obama Sees Strains Unless US, China Balance Growth
- JPMorgan Lifts Salary Freeze Amid Recovery
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- Do You Know Your Coca-Cola Myths?
- Buffett to Sell Stakes in Norfolk Southern, Union Pacific
- Cramer: 5 Stocks to Play the Next Bull Run
RSS FEED
Funny Business
Text Size 
 |
CNBC.com photo composite |
] disappointed the street this morning with its earnings report. Allergan is Fake Jane's favorite company. Even though earnings and sales were up double digits--sales topping a billion dollars for the first time in one quarter--the outlook is below street expectations, and an important drug trial failed. So, as blogged yesterday, Fake Jane will will be using her tax rebate to help save Allergan! She lives for the company's number one product--Botox. Sure, Botox is fighting efforts by Public Citizen to force the FDA to put warnings on Botox boxes suggesting it may have potential fatal side effects. This has not been proven, and Fake Jane doesn't really care! She's fake! Botox sales were pretty good in the fourth quarter, up 24 percent to $340 million, and up 23 percent for the year at $1.2 billion, nearly a third of the company's total income. That's a lot of shots.
Also of interest to Fake Jane is Allergan's "breast aesthetics" sector (can't we just say "implants"?). Sales here were up 38 percent for the quarter and 68 percent for the year! However, the company is only forecasting about 14 percent growth for 2008, in part because it's closing an implant facility in Ireland and moving production to Costa Rica. Well, duh. I mean, Fake Jane would much rather have a Costa Rican bust than the Irish one she inherited.
Meantime, the company reports a glaucoma drug it hoped to market failed to work better than a placebo in trials. Fake Jane will worry about glaucoma later. She's more interested in the deal the company has signed with Clinique to sell specialized skin care products.
Fake women of America... we must unite to keep these companies thriving in any economic downturn! It is better to look good than to look real. Judge for yourself with the results of Fake Jane's miraculous make-over.
 |
CNBC.com photo composite |
Comments? Funny Stories? Email
Data is a real-time snapshot *Data is delayed at least 15 minutes